Filing Flows › Clorox (CLX) › R&D spending
Clorox (CLX) R&D spending by quarter
Clorox's R&D spending was $29.0M in Q1 FY27 (first quarter fiscal 2027), +7% from Q3 FY26. Over the last 7 quarters it ranged from $27.0M (Q3 FY26) to $32.0M (Q4 FY25).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $29.0M | +7% | +4% |
| Q3 FY26 | $27.0M | -7% | 0% |
| Q2 FY26 | $29.0M | +4% | -6% |
| Q1 FY26 | $28.0M | -12% | — |
| Q4 FY25 | $32.0M | +19% | — |
| Q3 FY25 | $27.0M | -13% | — |
| Q2 FY25 | $31.0M | — | — |
Q1 FY27 at a glance
Clorox, Q1 FY27: revenue $1.9B (+33% year over year), operating margin 10.9%, net earnings $170M, operating cash flow $143M. The chart follows the revenue to costs, profit and cash.
Questions
What is Clorox's R&D spending?
Clorox's R&D spending was $29.0M in Q1 FY27 (first quarter fiscal 2027), +7% from Q3 FY26.
How has Clorox's R&D spending changed?
Over the last 7 quarters it ranged from $27.0M (Q3 FY26) to $32.0M (Q4 FY25).